Literature DB >> 12115156

Factors of importance for work disability in women with fibromyalgia: an interview study.

Gunilla M Liedberg1, Chris M Henriksson.   

Abstract

OBJECTIVE: Fibromyalgia symptoms such as continuous pain, tiredness, hyperalgesia, and allodynia limit gainful employment. The present study examines which factors influence the decision to remain in a work role for women with fibromyalgia. This information is important for the individual and for public finances.
METHODS: Qualitative interviews were performed with 39 women, 19 of whom were gainfully employed and 20 who had stopped working. The transcribed interviews were analyzed and divided into categories and subcategories.
RESULTS: Four categories appear, at societal and individual levels, that were regarded as important by the women for remaining in a work role.
CONCLUSIONS: The ability to remain at work depends not only on limitations in work capacity, but also on the capacity of society to adjust work environments and work tasks. More individual solutions are needed to allow women with fibromyalgia to maintain work roles.

Entities:  

Mesh:

Year:  2002        PMID: 12115156     DOI: 10.1002/art.10454

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

1.  Problems and accommodation strategies reported by computer users with rheumatoid arthritis or fibromyalgia.

Authors:  Nancy A Baker; Elaine N Rubinstein; Joan C Rogers
Journal:  J Occup Rehabil       Date:  2012-09

2.  Experiences of gout-related disability from the patients' perspective: a mixed methods study.

Authors:  Peter M ten Klooster; Harald E Vonkeman; Martijn A H Oude Voshaar; Christina Bode; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2014-08       Impact factor: 2.980

Review 3.  What work means to people with work disability: a scoping review.

Authors:  S L Saunders; B Nedelec
Journal:  J Occup Rehabil       Date:  2014-03

4.  Predictors for health improvement in patients with fibromyalgia: a 2-year follow-up study.

Authors:  Yvonne van Eijk-Hustings; Mariëlle Kroese; Annelies Boonen; Monique Bessems-Beks; Robert Landewé
Journal:  Clin Rheumatol       Date:  2013-08-24       Impact factor: 2.980

Review 5.  Patients' experiences of chronic non-malignant musculoskeletal pain: a qualitative systematic review.

Authors:  Francine Toye; Kate Seers; Nick Allcock; Michelle Briggs; Eloise Carr; JoyAnn Andrews; Karen Barker
Journal:  Br J Gen Pract       Date:  2013-12       Impact factor: 5.386

6.  Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective "real world" data analysis of fibromyalgia patients.

Authors:  Martin Offenbaecher; Niko Kohls; Thomas Ewert; Claudia Sigl; Robin Hieblinger; Loren L Toussaint; Fuschia Sirois; Jameson Hirsch; Miguel A Vallejo; Sybille Kramer; Javier Rivera; Gerold Stucki; Jörg Schelling; Andreas Winkelmann
Journal:  Rheumatol Int       Date:  2021-03-05       Impact factor: 2.631

7.  Hinders for continued work among persons with fibromyalgia.

Authors:  Kaisa Mannerkorpi; Gunvor Gard
Journal:  BMC Musculoskelet Disord       Date:  2012-06-11       Impact factor: 2.362

8.  Which aspects of health differ between working and nonworking women with fibromyalgia? A cross-sectional study of work status and health.

Authors:  Annie Palstam; Jan L Bjersing; Kaisa Mannerkorpi
Journal:  BMC Public Health       Date:  2012-12-14       Impact factor: 3.295

9.  Long-term sick-leavers with fibromyalgia: Comparing their multidisciplinarily assessed characteristics with those of others with chronic pain conditions and depression.

Authors:  Jürgen Linder; Kristina Schüldt Ekholm; Göran Lundh; Jan Ekholm
Journal:  J Multidiscip Healthc       Date:  2009-01-21

10.  Staying at work with chronic nonspecific musculoskeletal pain: a qualitative study of workers' experiences.

Authors:  Haitze J de Vries; Sandra Brouwer; Johan W Groothoff; Jan H B Geertzen; Michiel F Reneman
Journal:  BMC Musculoskelet Disord       Date:  2011-06-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.